Can Küçük | Health Threats | Innovative Research Award

Innovative Research Award

Can KüçükDokuz Eylul University, Turkey

Can Küçük
Affiliation Dokuz Eylul University
Country Turkey
Scopus ID 36771222700
Documents 39
Citations 2,568
h-index 16
Subject Area Health Threats
Event Global Diseases Research Awards
ORCID 0000-0001-5540-9012

Can Küçük is a researcher affiliated with Dokuz Eylul University in Turkey whose scholarly profile is associated with health threats and related research areas. The supplied Scopus information records 39 documents, 2,568 citations, and an h-index of 16. These indicators provide a bibliometric context for describing research productivity and scholarly visibility. [1]

Abstract

Can Küçük, affiliated with Dokuz Eylul University, Turkey, is presented in this academic recognition profile in relation to research concerning health threats. The supplied Scopus profile reports 39 scholarly documents, 2,568 citations, and an h-index of 16. These bibliometric indicators provide a concise representation of publication activity and citation performance within the indexed scholarly record. The profile is considered in the context of the Innovative Research Award associated with the Global Diseases Research Awards. The recognition framework considers documented research activity, subject relevance, scholarly visibility, and research contributions addressing health-related challenges. Such work can contribute to scientific understanding, evidence development, and responses to emerging and established threats to health. [1]

Keywords

Can Küçük; Innovative Research Award; health threats; Dokuz Eylul University; Turkey; Scopus; bibliometrics; research impact; global health; infectious diseases; scientific innovation; Global Diseases Research Awards. [1]

Introduction

Health threats encompass diverse biological, environmental, epidemiological, and public health challenges that can affect individuals and populations. Research addressing these threats contributes to disease understanding, prevention, diagnosis, treatment, preparedness, and evidence-based decision-making. Innovative approaches are particularly relevant where conventional methods require improvement or where emerging threats create new scientific and public health requirements. [2]

Research Profile

The supplied Scopus information identifies Can Küçük with Author ID 36771222700 and reports 39 documents, 2,568 citations, and an h-index of 16. These values describe the indexed scholarly record associated with the specified author profile. Bibliometric records can change over time as new publications are indexed, existing records are corrected, and citation databases are updated. [1]

Research Contributions

Research addressing health threats may involve multidisciplinary approaches spanning clinical science, epidemiology, microbiology, public health, diagnostics, therapeutics, and disease prevention. Küçük’s reported scholarly record establishes measurable research activity within the stated health-threat subject area. Evaluation of individual contributions should additionally consider originality, methodology, scientific findings, collaboration, and the practical or theoretical significance of specific studies.[3]

Publications

The supplied profile records 39 documents in Scopus. This document count provides a quantitative indication of indexed scholarly output but does not independently establish the quality or significance of individual publications. A publication-level assessment would require examination of article topics, study designs, journal characteristics, authorship contributions, findings, methodological rigor, and subsequent scholarly use. [1]

Research Impact

The reported citation count of 2,568 and h-index of 16 indicate substantial citation activity within the specified Scopus record. Citation-based measures can provide useful information about scholarly visibility and subsequent use of research, although interpretation should account for publication age, disciplinary citation practices, collaboration patterns, database coverage, and differences among research fields. [3]

Award Suitability

The Innovative Research Award profile is relevant to the stated subject area of health threats and the broader research focus of the Global Diseases Research Awards. Küçük’s academic affiliation, indexed publication activity, citation record, and h-index provide measurable evidence that can be considered during recognition assessment. Final evaluation should incorporate research originality, methodological quality, scientific contribution, publication evidence, and the applicable award criteria. [4]

Conclusion

Can Küçük’s supplied academic profile documents research activity at Dokuz Eylul University in Turkey within the subject area of health threats. The reported Scopus record of 39 documents, 2,568 citations, and an h-index of 16 provides a quantitative foundation for describing indexed scholarly presence. Further publication-level review can provide additional evidence regarding innovation, scientific quality, and research contribution.[5]

References

  1. Elsevier. (n.d.). Scopus author details: Can Küçük, Author ID 36771222700. Scopus.
    https://www.scopus.com/authid/detail.uri?authorId=36771222700
  2. Global Diseases Research Awards. (n.d.). Global Diseases Research Awards.
    https://globaldiseases.org/
  3. Cairns, R. A., Iqbal, J., Lemonnier, F., Kucuk, C., de Leval, L., Jais, J.-P., Parrens, M., Martin, A., Xerri, L., Brousset, P., Chan, L. C., Chan, W.-C., Gaulard, P., & Mak, T. W. (2012). IDH2 mutations are frequent in angioimmunoblastic T-cell lymphoma. Blood, 119(8), 1901–1903.
    https://doi.org/10.1182/blood-2011-11-391748

  4. Küçük, C., Jiang, B., Hu, X., Zhang, W., Chan, J. K. C., Xiao, W., Lack, N., Alkan, C., Williams, J. C., Avery, K. N., Kavak, P., Scuto, A., Sen, E., Gaulard, P., Staudt, L., Iqbal, J., Zhang, W., Cornish, A., Gong, Q., Yang, Q., Sun, H., d’Amore, F., Leppä, S., Liu, W., Fu, K., de Leval, L., McKeithan, T., & Chan, W. C. (2015). Activating mutations of STAT5B and STAT3 in lymphomas derived from γδ-T or NK cells. Nature Communications, 6, 6025.
    https://doi.org/10.1038/ncomms7025
  5. Iqbal, J., Weisenburger, D. D., Greiner, T. C., Vose, J. M., McKeithan, T., Kucuk, C., Geng, H., Deffenbacher, K., Smith, L., Dybkaer, K., Nakamura, S., Seto, M., Delabie, J., Berger, F., Loong, F., Au, W. Y., Ko, Y.-H., Sng, I., Armitage, J. O., & Chan, W. C., & International Peripheral T-Cell Lymphoma Project. (2009). Molecular signatures to improve diagnosis in peripheral T-cell lymphoma and prognostication in angioimmunoblastic T-cell lymphoma. Blood, 115(5), 1026–1036.
    https://doi.org/10.1182/blood-2009-06-227579

Alaa Hamza Abbas | Epidemiology | Best Researcher Award

Dr. Alaa Hamza Abbas | Epidemiology | Best Researcher Award 

Lecturer | Al-Mustaqbal University | Iraq

Dr. Alaa Hamza Abbas Sultan is a distinguished academic and researcher from Iraq, currently serving as Director of the Drugs and Forensic Poisons Information Center at Diwaniyah Health. He earned his Ph.D. and M.Sc. in Pharmacology from Al-Nahrain University, following a Bachelor of Pharmacy from Mosul University. His professional journey includes roles as a pharmacist, lecturer, certified trainer, and health administrator, contributing significantly to clinical pharmacology, medical education, and healthcare development. Dr. Abbas has been actively involved in reviewing for reputable journals and has participated in numerous international conferences, both as a researcher and reviewer. His research focuses on pharmacological interventions for metabolic disorders, inflammation, and dermatological conditions, with several impactful studies exploring the therapeutic effects of natural products and pharmacological agents, especially in models of hyperglycemia, hyperlipidemia, and psoriasis. Notable publications include articles in Naunyn-Schmiedeberg’s Archives of Pharmacology, ACS Pharmacology & Translational Science, and the Journal of Taibah University Medical Sciences. Beyond research, he contributes to teaching pharmacology, histology, and medical sciences, mentoring future professionals. His scholarly presence is recognized across Google Scholar, Scopus, ORCID, and Web of Science, reflecting his integration into the global scientific community. Dr. Abbas has authored 10 publications, which collectively received 165 citations from 48 documents, showcasing the relevance of his work. His contributions have earned him an h-index of 8, reflecting both productivity and citation impact in his field

Profiles:  ScopusGoogle Scholar | ORCID

Featured Publications

1. Salman, H. R., Alzubaidy, A. A., Abbas, A. H., & Mohammad, H. A. (2024). Attenuated effects of topical vinpocetine in an imiquimod-induced mouse model of psoriasis. Journal of Taibah University Medical Sciences, 19(1), 35–53. Cited by: 30

2. Hayder Ridha-Salman, D. M. H. S. A. M., Al-Zubaidy, A. A., & Abbas, A. H. (2024). The alleviative effects of canagliflozin on imiquimod-induced mouse model of psoriasis-like inflammation. Naunyn-Schmiedeberg’s Archives of Pharmacology, 398, 1–21. Cited by: 29*

3. Ridha-Salman, H., Shihab, E. M., Hasan, H. K., Abbas, A. H., Khorsheed, S. M., & others. (2024). Mitigative effects of topical norfloxacin on an imiquimod-induced murine model of psoriasis. ACS Pharmacology & Translational Science, 7(9), 2739–2754. Cited by: 29

4. Hayder Ridha-Salman, A. H. A. Q. A. Z., & Al-Zubaidy, A. A. (2023). The ameliorative effects of topical gemifloxacin alone or in combination with clobetasol propionate on imiquimod-induced model of psoriasis in mice. Naunyn-Schmiedeberg’s Archives of Pharmacology. Cited by: 28*

5. Abbas, A. H. (2023). The attenuated effects of Epagliflozin on imiquimod-induced model of psoriasis. Latin American Journal of Pharmacy, 42(Special Issue), 362–369. Cited by: 21